4 February 2016 - Deborah Wilkes
Archived
Switching Flonase to OTC status helped lift GlaxoSmithKline Consumer Healthcare's pro forma sales in the US by 22% at constant exchange rates during 2015.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.